Berlin Registry of Right Heart Interventions
Condition(s) studied
Investigational drug(s) / intervention(s)
Interventional therapy mainly of tricuspid regurgitation (TriClip, Cardioband): Catheter-based therapy of valve diseases of the right heart with various devices (e. g. TriClip, Cardioband).
Study summary
The present study evaluates patients after interventional therapy of valvular diseases of the right heart. Follow-up examinations include medical history taking, laboratory measurements and an echo. The aim is to assess the different interventional therapies and their impact on patient's outcome.
Eligibility
Primary outcome measure(s)
- Overall mortality — 2 months after intervention
Number of deceased participants after 2 months after intervention - Cardiovascular mortality — 2 months after intervention
Number of deceased participants after 2 months after intervention (cardiovascular cause of mortality) - Unscheduled hospitalization for heart failure progression — 2 months after intervention
Number of participants with unscheduled hospitalization for heart failure progression after 2 months after intervention
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Charité - Universitätsmedizin Berlin | Berlin | Germany | Recruiting |
More Charite University, Berlin, Germany trials in Germany
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04570163 on ClinicalTrials.gov ↗ ← All trials in Germany